secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvex, Inc. (MOVE)
CIK:        0001734750
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001213900-23-087243
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Movano Health to launch Evie Ring Nov 20; reports Q3 net loss $9.0M
-------------------------------------------------------------------

- Evie Ring launches Nov 20 at $269 with no subscription; shipping expected by year-end.
- Blood pressure SoC met FDA accuracy standards in clinical study; pivotal trial planned.
- FDA requested additional info on Evie Ring pulse oximeter 510(k); reply planned Q1 2024.
- Priced $3.6M public offering of 4.2M shares at $0.85; expected close Nov 17.
- Q3 net loss $9.0M ($0.18 loss per share); no revenue; pro forma cash $10.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734750/000121390023087243/0001213900-23-087243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734750/000121390023087243/ea188087-8k_movanoinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-087243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer